Two Cases of Monkeypox-Associated Encephalomyelitis — Colorado and the District of Columbia, July–August 2022
Daniel M. Pastula, Matthew J. Copeland, Markus C. Hannan, Samuel Rapaka, Takashi Kitani, Elizabeth Kleiner, Adrienne Showler, Cindy Yuen, Elizabeth M. Ferriman, Jennifer House, Shannon O’Brien, Alexis Burakoff, Bhavik Gupta, Kelli M. Money, Elizabeth Matthews, J. David Beckham, Lakshmi Chauhan, Amanda L. Piquet, Rebecca N. Kumar, Carlo Tornatore, Kia Padgett, Kevin O’Laughlin, Anil T. Mangla, Princy Kumar, Kenneth L. Tyler, Siobhán O’Connor
Abstract
Monkeypox virus (MPXV) is an orthopoxvirus in the Poxviridae family. The current multinational monkeypox outbreak has now spread to 96 countries that have not historically reported monkeypox, with most cases occurring among gay, bisexual, and other men who have sex with men (1,2). The first monkeypox case in the United States associated with this outbreak was identified in May 2022 in Massachusetts (1); monkeypox has now been reported in all 50 states, the District of Columbia (DC), and one U.S. territory. MPXV is transmitted by close contact with infected persons or animals; infection results in a febrile illness followed by a diffuse vesiculopustular rash and lymphadenopathy. However, illness in the MPXV current Clade II outbreak has differed: the febrile prodrome is frequently absent or mild, and the rash often involves genital, anal, or oral regions (3,4). Although neuroinvasive disease has been previously reported with MPXV infection (5,6), it appears to be rare. This report describes two cases of encephalomyelitis in patients with monkeypox disease that occurred during the current U.S. outbreak. Although neurologic complications of acute MPXV infections are rare, suspected cases should be reported to state, tribal, local, or territorial health departments to improve understanding of the range of clinical manifestations of and treatment options for MPXV infections during the current outbreak.